Crescita Therapeutics Inc. (TSE:CTX – Get Free Report)’s stock price was up 9.4% during trading on Monday . The company traded as high as C$0.60 and last traded at C$0.58. Approximately 256,556 shares traded hands during mid-day trading, an increase of 1,601% from the average daily volume of 15,085 shares. The stock had previously closed at C$0.53.
Crescita Therapeutics Stock Performance
The company’s 50-day moving average price is C$0.55 and its two-hundred day moving average price is C$0.57. The company has a debt-to-equity ratio of 5.77, a quick ratio of 2.29 and a current ratio of 2.70. The stock has a market cap of C$10.86 million, a PE ratio of -4.01 and a beta of 1.69.
Crescita Therapeutics Company Profile
Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.
Featured Articles
- Five stocks we like better than Crescita Therapeutics
- How to Buy Gold Stock and Invest in Gold
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- Dividend Capture Strategy: What You Need to Know
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- Stock Market Upgrades: What Are They?
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
